Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders.
LiveWorld Inc (LVWD) is expected to report for 3Q. Oncotelic Therapeutics Inc (OTLC) is expected to report for 3Q. Opus Genetics Inc (IRD) is expected to report $-0.33 for 3Q. Passage Bio Inc (PASG) ...
The Engulf Research Programme is a two-year project funded by the French Development Agency (AFD) and a collaboration between the University of Ghana, the French National Research Institute for ...
PHNOM PENH, CAMBODIA - Media OutReach Newswire - 7 November 2024 - The way people pay and get paid has changed more in the past five years than in the last 50. Consumers have evolved, adapting to new ...
This advertisement has not loaded yet, but your article continues below. Police exchanged gunfire with the man, which left him and an officer wounded Samples are on their way to Winnipeg's ...